Accomplished Principal Scientist with a proven track record at Servier, adept in vendor and external partner management, and leading analytical lifecycle management. Demonstrated excellence in technology transfer, significantly reducing drug substance hold time by 60%, and driving process improvements across commercial drugs. Skilled in collaborative problem-solving and technical guidance, underpinned by strong leadership and analytical capabilities.
· Led a matrix team of analytical scientists and improved a 1 cell culture product by reducing the manufacturing drying time from about 120 to 5 h and reduced alcohol consumption to 60%.
· Provided technical guidance in collaboration with SMEs to support root cause analysis and product impact assessments as demonstrated in providing 1 CAPA to solve product packaging and labeling issue.
· Collaborated with cross-functional teams including analytical development, process development, quality assurance, regulatory affairs as evidenced in qualifying 2 contract testing sites.
· Drove method qualification, validation, and transferred 1 method from one site 3 sites to improve raw material characterization.
· Performed a list of analytical tests in GLP environment to establish/support the drug product's shelf life and Improved 1 drug dissolution method of small molecule drug product.
· Authored/reviewed reports as sourced documents for inclusion in regulatory filings as demonstrated in reviewing analytical reports to support a filing in new markets.
· Performed analytical tests for a variety of products including solid oral dosage forms and recognized as a qualified reviewer to review peers reports.
· Set up a laboratory and led a team a to develop 1 prototype biosensor for food safety diagnostics.
· Collaborated with 4 external analytical laboratories in biologic analytics, wrote 1 protocol and multiple grant applications, and received $0.5M as investor funding.
· Led a team in critical analysis of laboratory operations, equipment and techniques and developed 1 biosensor.
· Developed analytical methods for large molecules and lead a group of scientists on multiple projects as demonstrated in 9 scientific publications.
Vendor and External Partner Management
Leading analytical life cycle management of 3 commercial drug products manufactured in CMOs (contract manufacturing organizations) and received a special bonus to stay focused on interacting with internal and external partners
Communication experience
· Demonstrated exceptional verbal and written communication skills and interpersonal skills as demonstrated in publishing 21 articles, presented in 20 international conferences.
· Reviewed the CMC sections of the BLA and wrote PAS to FDA, type IB variations to EMA and wrote in response to queries (RTQs) to multiple agencies (FDA, PMDA, ANVISA, EMA, Health Canada).
· Presented the lot out of specification (OOS) occurrences to the deviation review board meetings and received approval from the leadership on lot release/rejection.
Analytical development experience
· Led a matrix team of analytical scientists and accountable for development, manufacturing, release, stability testing, and characterization of drug substance and drug products as demonstrated in overseeing 3 drug products.
· As a matrix team leader, led analytical project in a broad analytical development role that spans from management of collaborations with appointed CDMOs and CROs as indicated proposing a new CDMO which received approval from the leadership.
Oversaw the development, execution, and strategic alignment of the organization goals and CDMO for successful development, regulatory submissions as indicated in receiving 2 new market approval.
Honors and awards
· Received a special bonus as a recognition to stay focused interacting with CMC organizations, CMOs and CROs to lead and manage analytical development activities (2023).
· Received the best PhD student oral presentation award at a conference (2014).